|
Irinotecan (drug) Clinical Trials
3 actively recruiting trials
Also known as: CPT-11
Pipeline
Phase 2: 1Phase 1/2: 2
Top Sponsors
- University of Birmingham1
- Sun Yat-sen University1
- Australian & New Zealand Children's Haematology/Oncology Group1
Indications
- Cancer3
- Childhood Solid Tumor1
- Childhood Brain Tumor1
- Refractory Cancer1
- BRAF V600 Colorectal Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.